线粒体呼吸链酶复合物在心肌缺血再灌注损伤中的作用进展  

Advances in the role of mitochondrial respiratory chain enzyme complexes in myocardial ischemiareperfusion injury

作　　者：李竹 王嫣 周雯静 王海英 LI Zhu;WANG Yan;ZHOU Wenjing;WANG Haiying(Department of Anesthesiology,Affiliated Hospital of Zunyi Medical University,Zunyi 563003,China;不详)

机构地区：[1]遵义医科大学附属医院麻醉科,贵州遵义563003 [2]贵州省麻醉与器官保护基础研究重点实验室,贵州遵义563000

出　　处：《实用医学杂志》2024年第15期2172-2176,共5页The Journal of Practical Medicine

基　　金：国家自然科学基金项目(编号:82260057)。

摘　　要：心肌缺血再灌注损伤(myocardial ischemia reperfusion injury,MIRI)是一种常见的心血管并发症,是困扰众多临床学者的一大难题。为改善MIRI预后众多学者致力于其机制的研究,发现线粒体与MIRI的发生密切相关,其中线粒体呼吸链酶复合物功能受损,能量代谢障碍在MIRI的发生过程中起着关键作用。本综述旨在阐述MIRI中线粒体呼吸链酶复合物的变化及其对MIRI的影响,为MIRI寻找新的有效治疗靶点提供依据。Myocardial ischemia reperfusion injury(MIRI)is a common cardiovascular complications,which is a major problem for many clinical scholars.To improve the prognosis of MIRI,many scholars have devoted to the research of its mechanism,and founded that mitochondria are closely related to the occurrence of MIRI,where the function of mitochondrial respiratory chain enzyme complex is impaired,and energy metabolism disorders play a key role in the process of MIRI.The aim of this review is to describe the changes of mitochondrial respiratory chain enzyme complex in MIRI and its effect on MIRI,and to provide a basis for finding new and effective therapeutic targets for MIRI.

关 键 词：心肌缺血再灌注损伤 线粒体酶复合物 线粒体呼吸链 

分 类 号：R363.2[医药卫生—病理学]